Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT

Bone Marrow Transplantation

Volumn 46, Issue 3, 2011, Pages 426-429

  Lucid, C E ^a   Savani, B N ^a   Engelhardt, B G ^a   Shah, P ^a   Clifton, C ^a   Greenhut, S L ^a   Vaughan, L A ^a   Kassim, A ^a   Schuening, F ^a   Jagasia, M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

bronchiolitis obliterans; extracorporeal photopheresis; GVHD; long term survivors; SCT

Indexed keywords

AZITHROMYCIN; CALCINEURIN INHIBITOR; METHOTREXATE; MONTELUKAST; MYCOPHENOLIC ACID; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PUVA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; BRONCHIOLITIS OBLITERANS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PHOTOPHERESIS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79952538578     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.152     Document Type: Article

References (24)

1. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14-21.
2. Williams KM, Chien JW, Gladwin MT, Pavletic SZ. Bronch-iolitis obliterans after allogeneic hematopoietic stem cell transplantation. J AmA 2009; 302: 306-314.
3. Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation\an increasingly recognized manifestation of chronic graft-verus-host disease. Biol Blood Marrow Transplant 2010; 16: S106-S114.
4. Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 223-230. (Pubitemid 40287921)
5. Savani BN, Montero A, Srinivasan R, Singh A, Shenoy A, Mielke S et al. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determi-nants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 1261-1269. (Pubitemid 44858271)
6. Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a rando-mized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006; 12: 560-565. (Pubitemid 43956361)
7. Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant 2009; 15: 1288-1295.
8. Couriel D, Hosing C, Saliba R, Shpall EJ, Andelini P, Popat U et al. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work? Biol Blood Marrow Transplant 2006; 12(1 Suppl 2): 37-40. (Pubitemid 43034110)
9. Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. JHeart Lung Transplant 2010; 29: 424-431.
10. Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208-214. (Pubitemid 36920975)
11. Khalid M, Al Saghir A, Saleemi S, Al Dammas S, Zeitouni M, Al Mobeireek A et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J2005; 25: 490-493. (Pubitemid 40340107)
12. Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchio-litis obliterans syndrome. J Heart Lung Transplant 2010; 29: 531-537.
13. Bashoura L, Gupta S, Jain A, Couriel DR, Komanduri KV, Eapen GA et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 63-67.
14. Fullmer JJ, Fan LL, Dishop MK, Rodgers C, Krance R. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade. Pediatrics 2005; 116: 767-770. (Pubitemid 44336698)
15. Majhail NS, Schiffer CA, Weisdorf DJ. Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplanta-tion. Biol Blood Marrow Transplant 2006; 12: 789-791. (Pubitemid 43899411)
16. Or R, Gesundheit B, Resnick I, Bitan M, Avraham A, AvgilM et al. Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study. Transplantation 2007; 83: 577-581. (Pubitemid 46440246)
17. Johnson BA, Iacono AT, Zeevi A, McCurry KR, Duncan SR. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 2003; 167: 1271-1278. (Pubitemid 36555101)
18. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460: 392-395.
19. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008; 105: 13051-13056.
20. Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179: 566-571.
21. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007; 104: 7552-7557. (Pubitemid 47185944)
22. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Ritz J et al. A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 28-35. (Pubitemid 350286734)
23. Iacono AT, Corcoran TE, Griffith BP, Grgurich WF, Smith DA, Zeevi A et al. Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur Respir J 2004; 23: 384-390. (Pubitemid 38344373)
24. Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006; 354: 141-150. (Pubitemid 43076711)